5ZK7 image
Entry Detail
PDB ID:
5ZK7
Title:
Stapled-peptides tailored against initiation of translation
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2018-03-23
Release Date:
2019-02-20
Method Details:
Experimental Method:
Resolution:
2.12 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Eukaryotic translation initiation factor 4E
Chain IDs:A, B
Chain Length:191
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:ACE-ARG-TYR-SER-ARG-MK8-GLN-LEU-LEU-MK8-LEU-PHE-ARG-NH2
Chain IDs:C, D
Chain Length:14
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Structural insights reveal a recognition feature for tailoring hydrocarbon stapled-peptides against the eukaryotic translation initiation factor 4E protein.
Chem Sci 10 2489 2500 (2019)
PMID: 30881679 DOI: 10.1039/c8sc03759k

Abstact

Stapled-peptides have emerged as an exciting class of molecules which can modulate protein-protein interactions. We have used a structure-guided approach to rationally develop a set of hydrocarbon stapled-peptides with high binding affinities and residence times against the oncogenic eukaryotic translation initiation factor 4E (eIF4E) protein. Crystal structures of these peptides in complex with eIF4E show that they form specific interactions with a region on the protein-binding interface of eIF4E which is distinct from the other well-established canonical interactions. This recognition element is a major molecular determinant underlying the improved binding kinetics of these peptides with eIF4E. The interactions were further exploited by designing features in the peptides to attenuate disorder and increase helicity which collectively resulted in the generation of a distinct class of hydrocarbon stapled-peptides targeting eIF4E. This study details new insights into the molecular basis of stapled-peptide: eIF4E interactions and their exploitation to enhance promising lead molecules for the development of stapled-peptide compounds for oncology.

Legend

Protein

Chemical

Disease

Primary Citation of related structures